Loading stock data…
Bruker Corporation (BRKR)
$59.71-1.20 (-1.97%)
After Hours$59.71+0.00 (+0.00%)· Last close Jun 29
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Bruker Corporation in the Healthcare sector is trading at $59.71 with a market capitalization of $8.6B. Wall Street consensus targets $53.83 (12 analysts), implying a -9.8% move over the next 12 months. The stock is currently near its 52-week high of $64.54, remaining 40.1% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply -9.8% downside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $823.40M↓ | $977.20M↑ | $860.50M↑ | $797.40M↓ | $801.40M |
| Gross Profit | $379.80M↓ | $449.20M↑ | $379.40M↑ | $357.90M↓ | $391.20M |
| Operating Income | $36.40M↓ | $111.80M↑ | $35.00M↑ | $26.30M↓ | $68.70M |
| Net Income | $14.40M↓ | $26.00M↑ | -$59.60M↓ | $7.60M↓ | $17.40M |
Peer Comparison
JNJUNHPFE
Fundamentals
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BS...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$8.59B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.33%
ROE
Average efficiency. Growth may require heavy reinvestment.
-0.47%
Volume
Today's trading volume
1.83M
Recent News
JPMorgan Maintains an “Overweight rating” on Bruker Corporation (BRKR)
Bruker Corporation (NASDAQ:BRKR) is one of the 10 Best Brain-Computer Interface Stocks to Buy. On June 8, JPMorgan analyst Casey Woodring raised the price target on Bruker Corporation (NASDAQ:BRKR) to $65 from $45. The firm maintained an “Overweight rating” on the share. It updated the company model. Days earlier, on June 4, Bruker Corporation (NASDAQ:BRKR) […]
Bruker (BRKR) Stock Trades Up, Here Is Why
Shares of scientific instrument company Bruker (NASDAQ:BRKR). jumped 4.2% in the morning session after Barclays raised its price target to $60, and optimism grew around the company's latest medical instrument launches.
Bruker Gains 50.3% in a Year: What's Driving the Rally?
BRKR's rally is fueled by BSI NANO growth, AI-driven metrology demand and gains in preclinical imaging despite tariff pressures.
What Bruker (BRKR)'s Expanded Diagnostics and Energy-Research Tools Portfolio Means For Shareholders
In early June 2026, Bruker expanded its microbiology diagnostics and high-resolution mass spectrometry portfolios, unveiling new MALDI Biotyper clinical capabilities, next‑generation NGS and sepsis workflows, and the timsMRMS platform for complex energy and materials research. These launches underline how Bruker is trying to link advanced analytical instruments with real-world applications in infectious disease management, sustainable fuels, and semiconductor and battery research. Now we’ll...
Is Bruker Corporation (BRKR) A Good Stock To Buy Now?
Is BRKR a good stock to buy? We came across a bullish thesis on Bruker Corporation on X.com by @BryzonX. In this article, we will summarize the bulls’ thesis on BRKR. Bruker Corporation’s share was trading at $58.44 as of June 1st. BRKR’s trailing and forward P/E were 66.98 and 15.22 respectively according to Yahoo Finance. Bruker […]